✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Vivanza Biosciences Ltd.

VIVANZA

Market Cap
₹10 Cr.
P/E
0.00

Vivanza Biosciences Ltd.

  • Vivanza Biosciences
  • Ambassador IntraHold
  • Longview Tea
FAQs on Vivanza Biosciences Ltd. Shareprice

Vivanza Biosciences has given lower returns compared to its competitors.
Vivanza Biosciences has grown at ~-26.69% over the last 4yrs while peers have grown at a median rate of 25.46%

Vivanza Biosciences is not expensive.
Latest PE of Vivanza Biosciences is 0.0, while 3 year average PE is 96.93.
Also latest EV/EBITDA of Vivanza Biosciences is 0.0 while 3yr average is 141.

View FAQ's On Business
Growth Table
  • Vivanza Biosciences Ltd.
  • Ambassador IntraHold
  • Longview Tea
Balance Sheet
  • Vivanza Biosciences Ltd.
  • Ambassador IntraHold
  • Longview Tea
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vivanza Biosciences Ltd.
  • Ambassador IntraHold
  • Longview Tea
Cash Flow
  • Vivanza Biosciences Ltd.
  • Ambassador IntraHold
  • Longview Tea
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vivanza Biosciences Ltd.
  • Ambassador IntraHold
  • Longview Tea
Quarterly Results
  • Vivanza Biosciences Ltd.
  • Ambassador IntraHold
  • Longview Tea
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Vivanza Biosciences Ltd. Financials

Balance sheet of Vivanza Biosciences is moderately strong.

Yes, The net debt of Vivanza Biosciences is increasing.
Latest net debt of Vivanza Biosciences is ₹8.54 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹5 Crs.

No, profit is decreasing.
The profit of Vivanza Biosciences is -₹0.68 Crs for TTM, ₹0.55 Crs for Mar 2024 and ₹0.6 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vivanza Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech